Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.4, 2011-04, pp. : 393-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Discovery to the Coming Generation of Histone Deacetylase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2351-2358

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve Dyke Hazel J

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite

Macrocyclic Histone Deacetylase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 593-601

Bentham Science Publishers

Access to resources Recommend Favorite